Please use this identifier to cite or link to this item:
|Title:||Horseradish peroxidase-crosslinked calcium-containing silk fibroin hydrogels as artificial matrices for bone cancer research|
Ribeiro, Viviana Pinto
Costa, Lígia Francisca Rodrigues
Pina, Sandra Cristina Almeida
da Silva Morais, Alain
Kundu, Subhas C
Reis, R. L.
Oliveira, J. M.
|Citation:||Pierantoni L., Ribeiro V. P., Costa L., Pina S., da Silva Morais A., Silva-Correia J., Kundu S. C., Motta A., Reis R. L., Oliveira J. M. Horseradish Peroxidase-Crosslinked Calcium-containing Silk Fibroin Hydrogels as Artificial Matrices for Bone Cancer Research, Macromolecular Bioscience, doi:10.1002/mabi.202000425, 2021|
|Abstract(s):||Hydrogels, being capable of mimicking the extracellular matrix composition of tissues, are greatly used as artificial matrices in tissue engineering applications. In this study, we report the generation of horseradish peroxidase (HRP)-crosslinked silk fibroin (SF) hydrogels, using calcium peroxide as oxidizer. The proposed fast forming calcium-containing SF hydrogels spontaneously undergo SF conformational changes from random coil to Î²-sheet during time, exhibiting ionic and pH stimuli responsiveness. In vitro response shows calcium-containing SF hydrogelsâ encapsulation properties and their ability to promote SaOs-2 tumor cells death after 10 days of culturing, upon complete Î²-sheet conformation transition. Calcium-containing SF hydrogelsâ angiogenic potential investigated in an in ovo chick chorioallantoic membrane (CAM) assay, show a high number of converging blood vessels as compared to the negative control, although no endothelial cells infiltration is observed. The in vivo response evaluated in subcutaneous implantation in CD1 and nude NCD1 mice shows that calcium-containing SF hydrogels are stable up to 6 weeks after implantation. However, an increased number of dead cells are also present in the surrounding tissue. The results suggest the potential of calcium-containing SF hydrogels to be used as novel in situ therapeutics for bone cancer treatment applications, particularly to osteosarcoma.|
|Description:||"Online ahead of print"|
|Access:||Restricted access (UMinho)|
|Appears in Collections:||3B’s - Artigos em revistas/Papers in scientific journals|
Files in This Item:
|2,05 MB||Adobe PDF||View/Open|